Medical Genetics

Genetics, Biology, and Look-Alike Conditions

At a Glance

TUD deficiency is an inherited cause of cerebellar ataxia, seizures, and intellectual disability. Because several SCAR conditions can look alike, whole exome sequencing or a broad gene panel helps identify the responsible gene and supports family testing, counseling, and future care.

When a child is diagnosed with a condition like Autosomal Recessive Cerebellar Ataxia-Epilepsy-Intellectual Disability Syndrome, it means their symptoms are driven by a specific change in their DNA. Because many different genes can cause nearly identical symptoms—ataxia (balance issues), epilepsy (seizures), and intellectual disability—doctors must use precision genetic testing to identify the exact “biological driver” ^[1]^[2].

Understanding Autosomal Recessive Inheritance

“Autosomal recessive” describes how a condition is passed from parents to children. We all have two copies of most genes—one from our mother and one from our father.

The Carrier State: In most cases, each parent is a carrier. This means they have one working copy of the gene and one “changed” (pathogenic) copy. Because the working copy does its job, carriers usually have no symptoms, though this is not universally identical across genes ^[3]^[4].
The Affected Child: If a child inherits the changed copy from both parents, they have a disrupted version of that gene, though some pathogenic variants retain partial function. This is called being homozygous (two identical changes) or compound heterozygous (two different changes in the same gene) ^[5]^[6].
The Odds: When both biological parents carry confirmed pathogenic variants in the exact same gene, each pregnancy has an independent 25% chance of the child having the condition, a 50% chance of the child being a carrier like the parents, and a 25% chance of the child inheriting only the working copies ^[3]. We recommend speaking with a genetic counselor to review your specific report.

Comparing Look-Alike Conditions

While the symptoms look similar on the outside, what is happening inside the cells is very different. Identifying the specific SCAR (Spinocerebellar Ataxia Recessive) type is the only way to fully understand the underlying biology.

Condition	Gene Involved	Biological “Glitch”	Supportive Clinical Clues
SCAR12	WWOX	Has roles in neuronal development and DNA-damage response ^[7].	Can range from mild ataxia to severe WOREE syndrome with very early infancy seizures ^[8]^[9].
SCAR23	TDP2	Prevents the brain from repairing certain types of DNA damage ^[10].	Often involves drug-resistant epilepsy; may show progressive balance issues into adulthood ^[11]^[10].
SCAR17	CWF19L1	Disrupts a protein involved in cell maintenance ^[2].	May include “extrapyramidal” movements (like tremors or stiff muscles) that worsen in adolescence ^[2]^[12].

Why Precision Testing Matters

Because these conditions overlap so much, a doctor cannot diagnose the specific gene just by looking at the child. Precision genetic testing (like Whole Exome Sequencing or Large Panels) is required for several reasons, but testing must be interpreted by specialists:

Defining Severity: Some WWOX variants cause severe early-onset encephalopathy, while others cause a milder ataxia. Knowing the specific variant helps set expectations for the future ^[8]^[9].
Ruling Out Other Mimics: Other conditions like SCAR20 (SNX14 gene) or SCAR13 (GRM1 gene) can also cause ataxia and intellectual disability but may have different associated risks, such as hearing loss or specific facial features ^[13]^[14].
Future Family Planning: Accurate diagnosis allows for reliable testing of other family members and informs reproductive counseling ^[15]^[2].
Research Access: As science advances, new treatments are often developed for one specific gene at a time. Having a precise genetic name ensures you are ready if a clinical trial or targeted therapy becomes available ^[15].

If initial testing does not provide a clear answer, doctors may recommend genetic re-analysis of the data a year or two later, as new genes are discovered every year ^[16]^[15].

Common questions in this guide

What symptoms are linked to TUD deficiency?

TUD deficiency syndrome is associated with cerebellar ataxia, which affects balance and coordination, along with epilepsy and intellectual disability. Developmental delays may also be part of the picture, and the combination and severity can differ among children.

Why can’t symptoms alone identify the gene causing my child’s ataxia?

Many inherited SCAR conditions can cause ataxia, seizures, and intellectual disability. Whole exome sequencing or a broad gene panel can examine many genes at once, but a genetics specialist must interpret the result together with the child’s clinical findings.

What does autosomal recessive inheritance mean for our family?

Usually, each parent carries one changed copy of the gene and has no symptoms. When both parents carry disease-causing variants in the same gene, each pregnancy has a 25% chance of being affected, a 50% chance of producing a carrier, and a 25% chance of inheriting neither changed copy.

What is the difference between homozygous and compound heterozygous variants?

Homozygous means that a child has two copies of the same disease-causing variant in a gene. Compound heterozygous means the child has two different disease-causing variants in the same gene, usually one inherited from each parent.

What can we do if genetic testing does not give a clear diagnosis?

Ask the genetics team whether the results should be re-analyzed in one or two years, because new genes and variant information may clarify an initially inconclusive result. Keep a copy of the full laboratory report to share with future specialists and for family counseling.

Why is finding the exact gene important?

The exact gene and variant can help explain differences in severity, guide testing of relatives, and support reproductive counseling. A precise diagnosis may also help families find relevant research studies or future gene-specific treatments.

Get notified when new evidence is published on Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (16)

1
The phenotypic spectrum of WWOX-related disorders: 20 additional cases of WOREE syndrome and review of the literature.
Piard J, Hawkes L, Milh M, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2019; (21(6)):1308-1318 doi:10.1038/s41436-018-0339-3.
PMID: 30356099
2
Expansion of the phenotypic and molecular spectrum of CWF19L1-related disorder.
Alvarez C, Grimmel M, Ebrahimi-Fakhari D, et al.
Clinical genetics 2023; (103(5)):566-573 doi:10.1111/cge.14275.
PMID: 36453471
3
Autosomal recessive frameshift variant broadens HECW2-related disease spectrum.
Dehghanzad R, Eshaghkhani Y, Saberi M, et al.
European journal of medical genetics 2025; (77()):105036 doi:10.1016/j.ejmg.2025.105036.
PMID: 40812465
4
Identification of a Novel Homozygous Missense (c.443A>T:p.N148I) Mutation in BBS2 in a Kashmiri Family with Bardet-Biedl Syndrome.
Ali G, Sadia , Foo JN, et al.
BioMed research international 2021; (2021()):6626015 doi:10.1155/2021/6626015.
PMID: 33688495
5
High diagnostic rate of trio exome sequencing in consanguineous families with neurogenetic diseases.
Hiz Kurul S, Oktay Y, Töpf A, et al.
Brain : a journal of neurology 2022; (145(4)):1507-1518 doi:10.1093/brain/awab395.
PMID: 34791078
6
Identification of a Novel Pathogenic ABCC6 Mutation Through Familial Genetic Analysis in Pseudoxanthoma Elasticum: A Case Report.
Liang L, Li R, Ren D, Zhou Y
Cureus 2026; (18(1)):e101655 doi:10.7759/cureus.101655.
PMID: 41552733
7
WWOX P47T partial loss-of-function mutation induces epilepsy, progressive neuroinflammation, and cerebellar degeneration in mice phenocopying human SCAR12.
Hussain T, Sanchez K, Crayton J, et al.
Progress in neurobiology 2023; (223()):102425 doi:10.1016/j.pneurobio.2023.102425.
PMID: 36828035
8
Modeling genetic epileptic encephalopathies using brain organoids.
Steinberg DJ, Repudi S, Saleem A, et al.
EMBO molecular medicine 2021; (13(8)):e13610 doi:10.15252/emmm.202013610.
PMID: 34268881
9
WWOX developmental and epileptic encephalopathy: Understanding the epileptology and the mortality risk.
Oliver KL, Trivisano M, Mandelstam SA, et al.
Epilepsia 2023; (64(5)):1351-1367 doi:10.1111/epi.17542.
PMID: 36779245
10
Characterization of a novel loss-of-function variant in TDP2 in two adult patients with spinocerebellar ataxia autosomal recessive 23 (SCAR23).
Errichiello E, Zagnoli-Vieira G, Rizzi R, et al.
Journal of human genetics 2020; (65(12)):1135-1141 doi:10.1038/s10038-020-0800-4.
PMID: 32651480
11
Consolidating the Role of TDP2 Mutations in Recessive Spinocerebellar Ataxia Associated with Pediatric Onset Drug Resistant Epilepsy and Intellectual Disability (SCAR23).
Ciaccio C, Castello R, Esposito S, et al.
Cerebellum (London, England) 2019; (18(5)):972-975 doi:10.1007/s12311-019-01069-7.
PMID: 31410782
12
A Novel Variant in CWF19L1 Gene in a Family with Late-Onset Autosomal Recessive Cerebellar Ataxia 17.
Algahtani H, Shirah B, Almatrafi S, et al.
Neurological research 2021; (43(2)):141-147 doi:10.1080/01616412.2020.1831331.
PMID: 33012273
13
Autosomal recessive spinocerebellar ataxia 20: Report of a new patient and review of literature.
Shukla A, Upadhyai P, Shah J, et al.
European journal of medical genetics 2017; (60(2)):118-123 doi:10.1016/j.ejmg.2016.11.006.
PMID: 27913285
14
Severe Neurodevelopmental Disorder in Autosomal Recessive Spinocerebellar Ataxia 13 (SCAR13) Caused by Two Novel Frameshift Variants in GRM1.
Cesaroni CA, Pisanò G, Trimarchi G, et al.
Cerebellum (London, England) 2024; (23(5)):1768-1771 doi:10.1007/s12311-023-01617-2.
PMID: 37831383
15
Exome sequencing for patients with developmental and epileptic encephalopathies in clinical practice.
Scheffer IE, Bennett CA, Gill D, et al.
Developmental medicine and child neurology 2023; (65(1)):50-57 doi:10.1111/dmcn.15308.
PMID: 35701389
16
Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohort.
Rochtus A, Olson HE, Smith L, et al.
Epilepsia 2020; (61(2)):249-258 doi:10.1111/epi.16427.
PMID: 31957018

This page is for informational purposes only and does not constitute medical advice about TUD deficiency. Your child's neurologist, clinical geneticist, and genetic counselor can interpret the report and discuss next steps.